RDY analyst estimates
Dr. Reddy's Laboratories (RDY) analyst ratings, the average price target and its range, and every firm's latest call.
RDY analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 25, 2026 | Jefferies | Dr. Reddy's upgraded to Hold from Underperform at Jefferies | $13.90 |
| Oct 12, 2026 | BNP Paribas | Dr. Reddy's upgraded to Outperform from Neutral at BNP Paribas | $14.80 |
- 0 firms rate RDY: 0 buy, 0 hold, 0 sell.
- The average price target is $14.35 from 2 analysts, from $13.90 to $14.80.
Updated 2026-11-02 23:12 UTC